NU.V - NeutriSci International Inc.

NeutriSci International Inc.

4015 - 1st Street SE
Suite #1A
Calgary, AB T2G 4X7
Canada
403-264-6320
http://www.neutrisci.com

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Glen Rehman	CEO & Director	150k	N/A	N/A
Mr. John Robert Chisholm	Chief Financial Officer	N/A	N/A	1962
Mr. Thierry Sorhaitz	VP of Sales & Marketing and Director	N/A	N/A	N/A
Mr. Barry Ross	Placement and Sales Mang.	N/A	N/A	N/A

Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

NeutriSci International Inc. develops and markets nutraceutical products in Canada and internationally. It offers Neuenergy, a chewable tablet designed to deliver enhanced focus and mental clarity; nu.thc and nu.cbd sugar-free chewable cannabinoid tablets that offer a metered dose of THC/CBD; and BluScience line of products to support optimal health. The company markets its products through retail and online channels. NeutriSci International Inc. is headquartered in Calgary, Canada.

Corporate Governance

NeutriSci International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.